Prion Disease: Diagnostic Strategies

Prion diseases are fatal neurodegenerative and infectious disorders characterized by structural transition of the host-encoded cellular prion protein into the aberrantly folded pathologic isoform of the protein. Here is the latest research on diagnostic strategies for prion diseases.

October 12, 2005
Open Access

The modern autopsy: what to do if infection is suspected

Archives of Medical Research
Edward L Mazuchowski, Patricia A Meier
September 4, 2013

Validation of next-generation sequencing technologies in genetic diagnosis of dementia

Neurobiology of Aging
John BeckSimon Mead
September 17, 2013
Open Access

A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases

Progress in Neurobiology
Jane S PaulsenJanet K Williams
July 11, 2006

Current and future molecular diagnostics for prion diseases

Expert Review of Molecular Diagnostics
Marty T LehtoNeil R Cashman
March 17, 2012
Open Access

New generation QuIC assays for prion seeding activity

Christina D OrrùByron Caughey
October 5, 2016
Open Access

Diagnosing Sporadic Creutzfeldt-Jakob Disease by the Detection of Abnormal Prion Protein in Patient Urine

JAMA Neurology
Connie LukGraham S Jackson
April 16, 2008
Case Report

Case of Gerstmann-Sträussler-Scheinker syndrome (GSS-P102L) mimicking variant Creurtzfeldt-Jakob disease in clinical manifestation and MRI findings

Rinshō shinkeigaku = Clinical neurology
Akiko KanataSusumu Kusunoki
February 27, 2013

Update on the Non-Huntington's Disease Choreas with Comments on the Current Nomenclature

Tremor and Other Hyperkinetic Movements
Ruth H Walker
August 16, 2018
Open Access

Impaired transmissibility of atypical prions from genetic CJDG114V

Neurology. Genetics
Ignazio CaliJames A Mastrianni
November 28, 2013
Open Access

Biology and genetics of prions causing neurodegeneration

Annual Review of Genetics
Stanley B Prusiner
October 11, 2017

Concepts and classification of neurodegenerative diseases

Handbook of Clinical Neurology
Gabor G Kovacs
July 7, 2020
Open Access

Insects in food and feed - allergenicity risk assessment and analytical detection

EFSA Journal
German Federal Institute for Risk Assessment (BfR), National Reference Laboratory for Animal protein in Feed, NRL‐APAlbert Braeuning
August 8, 2008
Open Access

Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin

The Biochemical Journal
Sabrina CronierJonathan D F Wadsworth
March 26, 2003

Bacillus anthracis, prions, Coxiella burnetii

Rinsho byori. The Japanese journal of clinical pathology
Katsuhiko Machida

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved